Video
Outsmarting the Heart: Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 2x
- 1.75x
- 1.5x
- 1.25x
- 1x, selected
- 0.75x
- 0.5x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
52:07
Barostim, a novel device therapy, complements GDMT by targeting neurohormonal pathways in heart failure. Here, experts discuss patient selection, outcomes, and strategies for integrating Barostim into care for patients with Class II/III HFrEF.
